靶向微转移:放射性核素异质分布对肿瘤控制概率的影响
本研究在MDA-MB-468、SQ20B和231-H2N细胞系球体微转移模型中,结合细胞内化实验、微放射自显影、γH2AX染色和克隆形成实验,并用蒙特卡洛剂量学与迭代建模计算生存分数及肿瘤控制概率。计算生存分数与实验数据吻合良好,尤其在提高核源自剂量相对生物效应并校正剂量迁延时;仅MDA-MB-468球体经111In-EGF处理时肿瘤控制概率>0.5。作者认为评估放射性核素分布须纳入生物学终点,空间分布是生物效应和肿瘤控制概率的决定因素。
要点
- 计算生存分数与实验生存分数吻合良好,尤其在校正核源自剂量相对生物效应和剂量迁延时。
- 仅MDA-MB-468球体经111In-EGF处理达到肿瘤控制概率>0.5,归因于该细胞相对放射敏感、核摄取高及放射性均匀分布。
- 作者认为评估放射性核素分布须纳入生物学终点,空间分布是生物效应和肿瘤控制概率的决定因素。
核心结论
- 作者认为评估放射性核素分布须纳入生物学终点,放射性空间分布是生物效应和肿瘤控制概率的决定因素。
研究设计与样本
- 研究用MDA-MB-468、SQ20B和231-H2N细胞系球体代表微转移模型。
- 通过细胞内化实验测定111In标记表皮生长因子和111In标记曲妥珠单抗的细胞内分布,并用球体微放射自显影评估瘤内分布。
- 对球体切片行γH2AX染色以关联DNA损伤与放射性核素分布,用克隆形成实验获得实验生存分数。
- 采用随机紧密堆积算法模拟三维球体,基于PENELOPE代码蒙特卡洛吸收剂量用迭代建模法生成计算生存分数并与实验生存分数比较。
- 用实验与蒙特卡洛模拟推得的放射生物学参数预测三维球体模型的肿瘤控制概率。
主要发现
- 计算生存分数与实验数据吻合良好,尤其在提高沉积于核内源的自剂量相对生物效应值并调整放射生物学参数以校正剂量迁延时。
- 仅MDA-MB-468球体经111In-EGF处理达到肿瘤控制概率>0.5,表明对该细胞类型放射性肽靶向微转移时可治愈。
- 该结果归因于MDA-MB-468细胞相对放射敏感、放射性肽核摄取高及放射性在球体内均匀分布。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The spatial distribution of radiopharmaceuticals that emit short-range high linear-energy-transfer electrons greatly affects the absorbed dose and their biological effectiveness. The purpose of this study was to investigate the effect of heterogeneous radionuclide distribution on tumor control probability (TCP) in a micrometastases model. Methods: Cancer cell lines; MDA-MB-468, SQ20B and 231-H2N were grown as spheroids to represent micrometastases. The intracellular distribution of a representative radiopeptide (111In-labelled epidermal growth factor, EGF) and radioimmunotherapeutic (111In-labelled Trastuzumab) was determined in cell internalization experiments. The intratumoral distribution was evaluated by microautoradiography of spheroids. γH2AX staining was performed on spheroid sections to correlate DNA damage with radionuclide distribution. Experimental surviving fractions (SFexp ) were obtained using clonogenic assays. A random closed-packed algorithm, which models the random packing behavior of cells and reflects variation in the radii of cells and nuclei, was used to simulate 3-D spheroids. Calculated survival fractions (SFcal ) were generated using an iterative modelling method based on Monte Carlo determined absorbed dose with the PENELOPE code and were compared to (SFexp ). Radiobiological parameters deduced from experimental results and MC simulations were used to predict the TCP for a 3-D spheroid model. Results: Calculated SFs were in good agreement with experimental data, particularly when an increased value for relative biological effectiveness (RBE) was applied to self-dose deposited by sources located in the nucleus and when radiobiological parameters were adjusted to account for dose protraction. Only in MDA-MB-468 spheroids treated with 111In-EGF was a TCP>0.5 achieved, indicating that for this cell type the radiopeptide would be curative when targeting micrometastases. This is attributed to the relative radiosensitivity of MDA-MB-468 cells, high nuclear uptake of the radiopeptide and uniform distribution of radioactivity throughout the spheroid. Conclusion: It is imperative to include biological endpoints when evaluating the distribution of radionuclides in models emulating micrometastatic disease. The spatial distribution of radioactivity is a clear determinant of biological effect and TCP as demonstrated in this study.
引用
- Falzone N, Lee BQ, Able S, et al. Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability. J Nucl Med. 2018. PMID: 29959216. doi:10.2967/jnumed.117.207308
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。